Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-001172
Filing Date
2026-01-02
Accepted
2026-01-02 18:49:48
Documents
1
Period of Report
2026-01-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 10071
  Complete submission text file 0001193125-26-001172.txt   11589
Mailing Address 200 - 3650 GILMORE WAY BURNABY British Columbia, Canada
Business Address 200 - 3650 GILMORE WAY BURNABY British Columbia, Canada (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY British Columbia, Canada
Business Address
MORTIMER IAN (Reporting) CIK: 0001619961 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 26503437